Application Sponsors
ANDA 204329 | NANG KUANG PHARM CO | |
Marketing Status
Application Products
001 | INJECTABLE;INTRAVENOUS | EQ 3MG BASE/3ML | 0 | IBANDRONATE SODIUM | IBANDRONATE SODIUM |
FDA Submissions
UNKNOWN; | ORIG | 1 | AP | 2021-06-16 | |
Submissions Property Types
TE Codes
CDER Filings
NANG KUANG PHARM CO
cder:Array
(
[0] => Array
(
[ApplNo] => 204329
[companyName] => NANG KUANG PHARM CO
[docInserts] => ["",""]
[products] => [{"drugName":"IBANDRONATE SODIUM","activeIngredients":"IBANDRONATE SODIUM","strength":"EQ 3MG BASE\/3ML","dosageForm":"INJECTABLE;INTRAVENOUS","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"06\/16\/2021","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"","inserts":"[]","notes":"> Label is not available on this site."}]
[supplements] =>
[actionDate] => 2021-06-16
)
)